ZymeCO is a Series a-stage Biotechnology company based in Colorado Springs, Colorado, United States with roughly 11-50 employees. ZymeCO's team spans 1 in data & analytics, 1 in marketing and 1 in sales. ZymeCO is led by Mark Slavens Ph.D., Chief Executive Officer, alongside Thaddaus Huber (Chief Technology Officer), Michael Cantrell (Founder/CSO), Phil Dwyer Jr (Vice President Sales Marketing) and Jenny Phillips (Director of Marketing).

Mark Slavens Ph.D. is the CEO of ZymeCO, serving as Chief Executive Officer. Mark Slavens Ph.D. leads the company and its executive team.

ZymeCO's leadership team is led by Mark Slavens Ph.D. (Chief Executive Officer) and includes Thaddaus Huber (Chief Technology Officer), Michael Cantrell (Founder/CSO), Phil Dwyer Jr (Vice President Sales Marketing), Jenny Phillips (Director of Marketing). Each runs a function within the company.

ZymeCO's team spans 1 in data & analytics, 1 in marketing and 1 in sales. Each department reports up to the leadership team, as shown in the org chart above.

ZymeCO's data & analytics team has 1 person, making it the largest team at ZymeCO.

ZymeCO's marketing team has 1 person, making it the second-largest team at ZymeCO.

ZymeCO's sales team has 1 person, making it the third-largest team at ZymeCO.

ZymeCO has 7 employees, of which 1 work in data & analytics, 1 in marketing and 1 in sales.

ZymeCO is headquartered in Colorado Springs, Colorado, United States.

ZymeCO is a Series a-stage company operating in Biotechnology.

To correct or remove a profile from ZymeCO's page, email info@insideorg.com with the name and page link. Verified requests are processed within a few business days.